Galectin-9 Triggers Neutrophil-Mediated Anticancer Immunity

In earlier studies, galectin-9 (Gal-9) was identified as a multifaceted player in both adaptive and innate immunity. Further, Gal-9 had direct cytotoxic and tumor-selective activity towards cancer cell lines of various origins. In the current study, we identified that treatment with Gal-9 triggered...

Descripción completa

Detalles Bibliográficos
Autores principales: Ustyanovska Avtenyuk, Natasha, Choukrani, Ghizlane, Ammatuna, Emanuele, Niki, Toshiro, Cendrowicz, Ewa, Lourens, Harm Jan, Huls, Gerwin, Wiersma, Valerie R., Bremer, Edwin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8772786/
https://www.ncbi.nlm.nih.gov/pubmed/35052746
http://dx.doi.org/10.3390/biomedicines10010066

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8772786/
https://www.ncbi.nlm.nih.gov/pubmed/35052746
http://dx.doi.org/10.3390/biomedicines10010066

Ejemplares similares